C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics experienced one notable insider trading transaction recently, involving a proposed sale of shares by an officer. This activity follows a period where the stock price declined significantly. The company's latest earnings report showed a positive surprise, yet market sentiment remains pressured as equity values hover near the lower end of their annual range.
Ticker: CCCC Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for C4 Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Adams Kendra Chief Financial Officer Officer
Transaction date
Planned sale
Price
416.30
Quantity 7,137 +24.9%
Value US$3,005,779
KENDRA ADAMS Officer Officer
Transaction date
Proposed sale
Price
43.92
Quantity 21,375
Value US$81,595
Mark Mossler Officer Officer
Transaction date
Proposed sale
Price
285.06
Quantity 2,343
Value US$1,760,796
2.5
JAY GELDMACHER Former REZI CEO
Transaction date
Proposed sale
Price
23.01
Quantity 82,563
Value US$1,899,926
Mark Mossler Officer Officer
Transaction date
Proposed sale
Price
4.07
Quantity 15,000
Value US$61,072
Mark Mossler Officer Officer
Transaction date
Proposed sale
Price
3.93
Quantity 19,519
Value US$76,680
Mark Mossler Former Section 16 Officer Officer
Transaction date
Proposed sale
Price
3.91
Quantity 9,087
Value US$35,485
JOLIE M SIEGEL Officer Officer
Transaction date
Proposed sale
Price
3.74
Quantity 101,175
Value US$378,849
1.4
REYNO LEONARD Chief Medical Officer Officer
Transaction date
Sale
Price
2.22
Quantity 10,000 -6.0%
Value US$22,200
Boyle Scott N Chief Business Officer Officer
Transaction date
Planned sale
Price
3.15
Quantity 669 -0.6%
Value US$2,107
Boyle Scott N Chief Business Officer Officer
Transaction date
Planned sale
Price
3.15
Quantity 490 -0.4%
Value US$1,544
Salter Malcolm Director Non-Executive Director
Transaction date
Proposed sale
Price
4.19
Quantity 13,000
Value US$54,532
Salter Malcolm Director Non-Executive Director
Transaction date
Proposed sale
Price
6.41
Quantity 13,000
Value US$83,321
Salter Malcolm Director Non-Executive Director
Transaction date
Proposed sale
Price
5.38
Quantity 8,561
Value US$46,061
0.5
Koppikar Utpal Non-Executive Director
Transaction date
Purchase
Price
5.60
Quantity 5,667 New position
Value US$31,735
2.3
Hirsch Andrew President & CEO Executive Director
Transaction date
Purchase
Price
8.40
Quantity 10,000 New position
Value US$84,000
1.7
Crystal Adam Chief Medical Officer Officer
Transaction date
Planned sale
Price
32.66
Quantity 1,054 -6.6%
Value US$34,420
1.7
Crystal Adam Chief Medical Officer Officer
Transaction date
Planned sale
Price
31.59
Quantity 13,946 -46.5%
Value US$440,547
Salter Malcolm Non-Executive Director
Transaction date
Planned sale
Price
30.25
Quantity 755 -6.4%
Value US$22,839
Salter Malcolm Non-Executive Director
Transaction date
Planned sale
Price
40.11
Quantity 755 -6.1%
Value US$30,283
Salter Malcolm Non-Executive Director
Transaction date
Planned sale
Price
44.94
Quantity 755 -5.7%
Value US$33,930
1.7
Crystal Adam Chief Medical Officer Officer
Transaction date
Planned sale
Price
45.99
Quantity 5,112 -100.0%
Value US$235,119
1.7
Crystal Adam Chief Medical Officer Officer
Transaction date
Planned sale
Price
45.32
Quantity 8,176 -61.5%
Value US$370,563
1.7
Crystal Adam Chief Medical Officer Officer
Transaction date
Planned sale
Price
44.25
Quantity 1,712 -11.4%
Value US$75,756
Prokupets Elena Non-Executive Director
Transaction date
Planned sale
Price
50.04
Quantity 1,311 -0.3%
Value US$65,604
Prokupets Elena Non-Executive Director
Transaction date
Planned sale
Price
50.04
Quantity 539 -1.7%
Value US$26,969
Prokupets Elena Non-Executive Director
Transaction date
Planned sale
Price
50.07
Quantity 3,330 -0.6%
Value US$166,743
Prokupets Elena Non-Executive Director
Transaction date
Planned sale
Price
50.07
Quantity 3,330 -3.8%
Value US$166,730
Prokupets Elena Non-Executive Director
Transaction date
Planned sale
Price
50.01
Quantity 1,320 -0.2%
Value US$66,010
Prokupets Elena Non-Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 1,230 -1.4%
Value US$61,501
Siegel Jolie Chief Legal Officer Officer
Transaction date
Planned sale
Price
50.00
Quantity 12,500 -100.0%
Value US$625,000
Prokupets Elena Non-Executive Director
Transaction date
Planned sale
Price
45.01
Quantity 4,257 -4.0%
Value US$191,606
Prokupets Elena Non-Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 11,336 -9.6%
Value US$510,168
1.7
Crystal Adam Chief Medical Officer Officer
Transaction date
Planned sale
Price
45.00
Quantity 15,000 -100.0%
Value US$675,000
Salter Malcolm Non-Executive Director
Transaction date
Planned sale
Price
37.37
Quantity 755 -5.0%
Value US$28,214
Salter Malcolm Non-Executive Director
Transaction date
Planned sale
Price
37.19
Quantity 755 -4.8%
Value US$28,078
Salter Malcolm Non-Executive Director
Transaction date
Planned sale
Price
37.12
Quantity 755 -4.6%
Value US$28,026
1.7
Crystal Adam Chief Medical Officer Officer
Transaction date
Planned sale
Price
38.00
Quantity 10,879 -100.0%
Value US$413,407
1.7
Crystal Adam Chief Medical Officer Officer
Transaction date
Planned sale
Price
37.16
Quantity 4,121 -27.5%
Value US$153,129
Salter Malcolm Non-Executive Director
Transaction date
Purchase
Price
19.00
Quantity 1,315 +9.0%
Value US$24,985
3.3
COHEN MARC A Non-Executive Director Large shareholder
Transaction date
Purchase
Price
19.00
Quantity 5,030 New position
Value US$95,570
MCKEE WILLIAM Chief Financial Officer Officer
Transaction date
Purchase
Price
19.00
Quantity 5,263 New position
Value US$99,997
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-13 2026-11-12 PlS Planned sale

Chief Financial Officer

Officer
7,137 +24.9%
416.30
US$3,005,779
7,137 +24.9% 416.30 US$3,005,779
2026-11-12 2026-11-12 PrS Proposed sale

Officer

Officer
21,375
43.92
US$81,595
21,375 43.92 US$81,595
2026-08-14 2026-08-14 PrS Proposed sale

Officer

Officer
2,343
285.06
US$1,760,796
2,343 285.06 US$1,760,796
2026-08-14 2026-08-14 PrS Proposed sale

Former REZI CEO

82,563
23.01
US$1,899,926
82,563 23.01 US$1,899,926
2026-08-13 2026-08-13 PrS Proposed sale

Officer

Officer
15,000
4.07
US$61,072
15,000 4.07 US$61,072
2026-08-12 2026-08-12 PrS Proposed sale

Officer

Officer
19,519
3.93
US$76,680
19,519 3.93 US$76,680
2026-05-28 2026-05-27 PrS Proposed sale

Former Section 16 Officer

Officer
9,087
3.91
US$35,485
9,087 3.91 US$35,485
2026-03-09 2026-03-09 PrS Proposed sale

Officer

Officer
101,175
3.74
US$378,849
101,175 3.74 US$378,849
2026-01-16 2026-01-16 S Sale

Chief Medical Officer

Officer
10,000 -6.0%
2.22
US$22,200
10,000 -6.0% 2.22 US$22,200
2025-02-18 2025-02-18 PlS Planned sale

Chief Business Officer

Officer
669 -0.6%
3.15
US$2,107
669 -0.6% 3.15 US$2,107
2025-02-18 2025-02-14 PlS Planned sale

Chief Business Officer

Officer
490 -0.4%
3.15
US$1,544
490 -0.4% 3.15 US$1,544
2024-11-18 2024-11-18 PrS Proposed sale

Director

Non-Executive Director
13,000
4.19
US$54,532
13,000 4.19 US$54,532
2024-10-18 2024-10-18 PrS Proposed sale

Director

Non-Executive Director
13,000
6.41
US$83,321
13,000 6.41 US$83,321
2024-10-11 2024-10-11 PrS Proposed sale

Director

Non-Executive Director
8,561
5.38
US$46,061
8,561 5.38 US$46,061
2023-02-10 2023-02-08 B Purchase Non-Executive Director
5,667 New position
5.60
US$31,735
5,667 New position 5.60 US$31,735
2022-04-12 2022-04-12 B Purchase

President & CEO

Executive Director
10,000 New position
8.40
US$84,000
10,000 New position 8.40 US$84,000
2022-01-05 2022-01-04 PlS Planned sale

Chief Medical Officer

Officer
1,054 -6.6%
32.66
US$34,420
1,054 -6.6% 32.66 US$34,420
2022-01-05 2022-01-04 PlS Planned sale

Chief Medical Officer

Officer
13,946 -46.5%
31.59
US$440,547
13,946 -46.5% 31.59 US$440,547
2021-12-17 2021-12-17 PlS Planned sale Non-Executive Director
755 -6.4%
30.25
US$22,839
755 -6.4% 30.25 US$22,839
2021-11-19 2021-11-19 PlS Planned sale Non-Executive Director
755 -6.1%
40.11
US$30,283
755 -6.1% 40.11 US$30,283
2021-10-15 2021-10-15 PlS Planned sale Non-Executive Director
755 -5.7%
44.94
US$33,930
755 -5.7% 44.94 US$33,930
2021-10-05 2021-10-01 PlS Planned sale

Chief Medical Officer

Officer
5,112 -100.0%
45.99
US$235,119
5,112 -100.0% 45.99 US$235,119
2021-10-05 2021-10-01 PlS Planned sale

Chief Medical Officer

Officer
8,176 -61.5%
45.32
US$370,563
8,176 -61.5% 45.32 US$370,563
2021-10-05 2021-10-01 PlS Planned sale

Chief Medical Officer

Officer
1,712 -11.4%
44.25
US$75,756
1,712 -11.4% 44.25 US$75,756
2021-09-29 2021-09-27 PlS Planned sale Non-Executive Director
1,311 -0.3%
50.04
US$65,604
1,311 -0.3% 50.04 US$65,604
2021-09-29 2021-09-27 PlS Planned sale Non-Executive Director
539 -1.7%
50.04
US$26,969
539 -1.7% 50.04 US$26,969
2021-09-14 2021-09-13 PlS Planned sale Non-Executive Director
3,330 -0.6%
50.07
US$166,743
3,330 -0.6% 50.07 US$166,743
2021-09-14 2021-09-13 PlS Planned sale Non-Executive Director
3,330 -3.8%
50.07
US$166,730
3,330 -3.8% 50.07 US$166,730
2021-09-14 2021-09-10 PlS Planned sale Non-Executive Director
1,320 -0.2%
50.01
US$66,010
1,320 -0.2% 50.01 US$66,010
2021-09-14 2021-09-10 PlS Planned sale Non-Executive Director
1,230 -1.4%
50.00
US$61,501
1,230 -1.4% 50.00 US$61,501
2021-09-14 2021-09-10 PlS Planned sale

Chief Legal Officer

Officer
12,500 -100.0%
50.00
US$625,000
12,500 -100.0% 50.00 US$625,000
2021-08-02 2021-08-02 PlS Planned sale Non-Executive Director
4,257 -4.0%
45.01
US$191,606
4,257 -4.0% 45.01 US$191,606
2021-08-02 2021-07-29 PlS Planned sale Non-Executive Director
11,336 -9.6%
45.00
US$510,168
11,336 -9.6% 45.00 US$510,168
2021-08-02 2021-07-29 PlS Planned sale

Chief Medical Officer

Officer
15,000 -100.0%
45.00
US$675,000
15,000 -100.0% 45.00 US$675,000
2021-07-19 2021-07-16 PlS Planned sale Non-Executive Director
755 -5.0%
37.37
US$28,214
755 -5.0% 37.37 US$28,214
2021-06-21 2021-06-18 PlS Planned sale Non-Executive Director
755 -4.8%
37.19
US$28,078
755 -4.8% 37.19 US$28,078
2021-05-24 2021-05-21 PlS Planned sale Non-Executive Director
755 -4.6%
37.12
US$28,026
755 -4.6% 37.12 US$28,026
2021-04-06 2021-04-05 PlS Planned sale

Chief Medical Officer

Officer
10,879 -100.0%
38.00
US$413,407
10,879 -100.0% 38.00 US$413,407
2021-04-06 2021-04-05 PlS Planned sale

Chief Medical Officer

Officer
4,121 -27.5%
37.16
US$153,129
4,121 -27.5% 37.16 US$153,129
2020-10-06 2020-10-06 B Purchase Non-Executive Director
1,315 +9.0%
19.00
US$24,985
1,315 +9.0% 19.00 US$24,985
2020-10-06 2020-10-06 B Purchase Non-Executive Director Large shareholder
5,030 New position
19.00
US$95,570
5,030 New position 19.00 US$95,570
2020-10-06 2020-10-06 B Purchase

Chief Financial Officer

Officer
5,263 New position
19.00
US$99,997
5,263 New position 19.00 US$99,997